or
forgot password
  • cancer clinical trials in chattanooga, TN

  • Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC
    Associates in Hematology Oncology
    Chattanooga, Tennessee 37404
    Non-Small Cell Lung Cancer
    Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer
    Research Site
    Chattanooga, Tennessee
    Metastatic Colorectal Cancer, Colon Cancer, Colorectal Cancer, Rectal Cancer
    AMG 655/Panitumumab Combination Metastatic Colorectal Cancer Study
    Research Site
    Chattanooga, Tennessee
    Colon Cancer, Colorectal Cancer, Rectal Cancer, Metastatic Colorectal Cancer, Oncology
    Rituximab, Lenalidomide, and Bortezomib in Mantle Cell Lymphoma
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Mantle Cell Lymphoma
    CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
    Research Site
    Chattanooga, Tennessee
    Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma
    Study to Evaluate Exemestane With and Without SNDX-275 in Treatment of Postmenopausal Women With Advanced Breast Cancer
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Breast Cancer, Estrogen Receptor-Positive Breast Cancer, Breast Cancer, Estrogen Receptor-Positive, ER+ Breast Cancer
    Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer
    Chattanooga Oncology and Hematology Associates
    Chattanooga, Tennessee 37404
    Non Small Cell Lung Cancer
    Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
    Chattanooga Oncology and Hematology Assoicates, PC Memorial Plaza
    Chattanooga, Tennessee 37404
    Myelogenous Leukemia, Chronic
    Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Renal Cell Carcinoma
    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
    T C Thompson Children's Hospital
    Chattanooga, Tennessee 37403
    Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
    Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Carcinoma
    Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
    Blood Assurance, Inc.
    Chattanooga, Tennessee 37403
    Healthy
    A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer
    Chattanooga Oncology Hematology Associates

    Trial Locations
    Chattanooga Oncology Hematology Associates
    Associates in Hematology Oncology
    Breast Cancer
    Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
    T C Thompson Children's Hospital
    Chattanooga, Tennessee 37403
    Adult Rhabdomyosarcoma, Adult Synovial Sarcoma, Childhood Hepatoblastoma, Childhood Synovial Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adrenocortical Carcinoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Retinoblastoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    Sorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery
    Erlanger Cancer Center at Erlanger Hospital - Baroness
    Chattanooga, Tennessee 37403
    Pancreatic Cancer
    Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Metastatic Pancreatic Cancer
    Efficacy and Safety of MORAb-003 in Subjects With Platinum-sensitive Ovarian Cancer in First Relapse
    Chattanooga's Program in Women's Oncology
    Chattanooga, Tennessee 37403
    Ovarian Cancer
    Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
    Research Site
    Chattanooga, Tennessee
    Non-Small Cell Lung Cancer, Anemia, Cancer, Lung Cancer
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    Erlanger Medical Center
    Chattanooga, Tennessee 37403
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma
    Associates in Oncology and Hematology
    Chattanooga, Tennessee 37404
    Peripheral T-cell Lymphoma
    Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Breast Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
    T.C. Thompson Children's Hospital
    Chattanooga, Tennessee 37403
    Leukemia
    Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
    Erlanger Medical Center
    Chattanooga, Tennessee 37403
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Trial of Poor Performance Status Patients (ToPPS)
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Non Small Cell Lung Cancer
    Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Metastatic Breast Cancer
    Collecting Tumor Samples From Patients With Gynecological Tumors
    Chattanooga's Program in Women's Oncology
    Chattanooga, Tennessee 37403
    Cancer
    Study of Kidney Tumors in Young Patients
    T.C. Thompson Children's Hospital
    Chattanooga, Tennessee 37403
    Kidney Cancer, Nonneoplastic Condition
    Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma
    T.C. Thompson Children's Hospital
    Chattanooga, Tennessee 37403
    Sarcoma
    Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
    T.C. Thompson Children's Hospital
    Chattanooga, Tennessee 37403
    Sarcoma
    Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
    T.C. Thompson Children's Hospital
    Chattanooga, Tennessee 37403
    Lymphoma
    Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
    T.C. Thompson Children's Hospital
    Chattanooga, Tennessee 37403
    Neuroblastoma
    Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Non Small Cell Lung Cancer
    PAVES: Pegfilgrastim Anti-VEGF Evaluation Study
    Research Site
    Chattanooga, Tennessee
    Cancer, Colon Cancer, Colorectal Cancer, Fever, Locally Advanced, Metastatic Colorectal Cancer, Neutropenia, Rectal Cancer
    Trial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast Cancer
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Metastatic Breast Cancer
    Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
    T C Thompson Children's Hospital
    Chattanooga, Tennessee 37403
    Adult Rhabdomyosarcoma, Childhood Desmoplastic Small Round Cell Tumor, Chordoma, Desmoid Tumor, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
    T.C. Thompson Children's Hospital
    Chattanooga, Tennessee 37403
    Brain and Central Nervous System Tumors
    A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
    Research Site
    Chattanooga, Tennessee
    Cancer, Cataract, Low Bone Mineral Density, Osteopenia, Osteoporosis, Prostate Cancer
    Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients
    Chattanooga Oncology and Hematology Associates, PC
    Chattanooga, Tennessee 37404
    Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Erlanger Medical Center
    Chattanooga, Tennessee 37403
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Study of Blood Samples From Newborns With Down Syndrome
    T.C. Thompson Children's Hospital
    Chattanooga, Tennessee 37403
    Leukemia
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer
    T C Thompson Children's Hospital
    Chattanooga, Tennessee 37403
    Childhood Hepatoblastoma, Stage I Childhood Liver Cancer, Stage II Childhood Liver Cancer, Stage III Childhood Liver Cancer, Stage IV Childhood Liver Cancer
    Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Metastatic Melanoma
    LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer
    1199.15.10006 Boehringer Ingelheim Investigational Site
    Chattanooga, Tennessee
    Ovarian Neoplasms, Peritoneal Neoplasms
    Electronic Brachytherapy for the Treatment of NMSC
    Parkridge Medical Center - Sara Cannon Cancer Center
    Chattanooga, Tennessee 37404
    Basal Cell Carcinoma, Squamous Cell Carcinoma
    Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Erlanger Cancer Center at Erlanger Hospital - Baroness
    Chattanooga, Tennessee 37403
    Lung Cancer
    Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine
    Associates in Oncology and Hematology
    Chattanooga, Tennessee 37404
    Pancreatic Cancer, Ductal Adrenocarcinoma, Exocrine Pancreatic Cancer
    Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
    T C Thompson Children's Hospital
    Chattanooga, Tennessee 37403
    Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage IV Childhood Hodgkin Lymphoma
    Randomized, Double-Blind, Erlotinib/ Pazopanib or Erlotinib/ Placebo, Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer(NSCLC)
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Non Small Cell Lung Cancer
    Trial of Bendamustine, Bortezomib, and Rituximab in Patients With Previously Untreated Low Grade Lymphoma
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Lymphoma
    Use of PRO Onc Assay to Assess HER2 in Patients With Metastatic Breast Cancer
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Breast Cancer
    A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Extensive-Stage Small Cell Lung Cancer
    Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)
    Investigational Site Number 840103

    Trial Locations
    Investigational Site Number 840103
    Investigational Site Number 840208
    Squamous Cell Lung Cancer
    Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Neuroendocrine Carcinoma, Neuroendocrine
    Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    Erlanger Medical Center
    Chattanooga, Tennessee 37403
    Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma
    Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    T.C. Thompson Children's Hospital
    Chattanooga, Tennessee 37403
    Leukemia